Publications
Development of an anthropomorphic spine phantom suitable for fusion of MR neurography with interventional flat-panel CT
Kobe A., Zadory M., Hamie Q.M., Froehlich J. M., Klarhöfer M., Elsässer T., Pfammatter T., Guggenberger R.
Eur. J. Radiol., vol. 112, pp. 153–160, mars 2019, doi: 10.1016/j.ejrad.2019.01.019.
In vitro qualitative and quantitative CT assessment of iodinated aerosol nasal deposition using a 3D-printed nasal replica
Sartoretti T., Mannil M., Biendl s., Froehlich J. M., Alkadhi H., Zadory M.
Eur. Radiol. Exp., vol. 3, no. 1, p. 32, août 2019, doi: 10.1186/s41747-019-0113-6.
Gadolinium distribution in cerebrospinal fluid after administration of a gadolinium-based MR contrast agent in humans
Berger F., Kubik-Huch R. A., Niemann T., Schmid H. R., Poetzsch M., Froehlich J. M., Beer J. H., Thali M. J., Kraemer T.
Radiology, vol. 288, no. 3, pp. 703–709, sept. 2018, doi: 10.1148/radiol.2018171829.
Functional and targeted lymph node imaging in prostate cancer: Current status and future challenges
Thoeny H. C., Barbieri S., Froehlich J. M., Turkbey B., Choyke P. L.
Radiology, vol. 285, no. 3. Radiological Society of North America Inc., pp. 728–743, déc. 01, 2017, doi: 10.1148/radiol.2017161517.
Does quantification of USPIO uptake-related signal loss allow differentiation of benign and malignant normal-sized pelvic lymph nodes?
Froehlich J. M., Triantafyllou M., Fleischmann A., Vermathen P., Thalmann G. N., Thoeny H. C.
Contrast Media Mol. Imaging, vol. 7, no. 3, pp. 346–355, mai 2012, doi: 10.1002/cmmi.503.
Feasibility of small bowel flow rate measurement with MRI
Gutzeit A., Patak M. A., von Weymarn C., Graf N., Doert A., Willemse E., Binkert C. A., Froehlich J. M.
Magn. Reson. Imaging, vol. 32, no. 2, pp. 345–351, août 2010, doi: 10.1002/jmri.22254.
Pharmacokinetics and pharmacodynamics of nasally delivered midazolam
Haschke M., Suter K., Hofmann S., Witschi R., Fröhlich J., Imanidis G., Drewe J., Briellmann T. A., Dussy F. E., Krähenbühl S., Surber C.
Br. J. Clin. Pharmacol., vol. 69, no. 6, pp. 607–616, 2010, doi: 10.1111/j.1365-2125.2010.03611.x.
Multicenter trial: Comparison of two different formulations and application systems of low-dose nasal midazolam for routine magnetic resonance imaging of claustrophobic patients
Tschirch F.T., Suter K., Froehlich J. M., Studler U., Nidecker A., Eckhardt B., Beranek-Chiu J., Surber C., Weishaupt D.
Magn. Reson. Imaging, vol. 28, no. 4, pp. 866–872, oct. 2008, doi: 10.1002/jmri.21552.
Low-dose intranasal versus oral midazolam for routine body MRI of claustrophobic patients
Tschirch FT., Göpfert K., Fröhlich JM., Brunner G., Weishaupt D.
Eur. Radiol., vol. 17, no. 6, pp. 1403–1410, juin 2007, doi: 10.1007/s00330-006-0457-1.
Small bowel motility assessment with magnetic resonance imaging
Froehlich J. M., Patak M. A., von Weymarn C., Juli C. F., Zollikofer C. L., Wentz K. U.
Magn. Reson. Imaging, vol. 21, no. 4, pp. 370–375, avr. 2005, doi: 10.1002/jmri.20284.
Distinctions
Prix du meilleur poster « summa cum laude » :
An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release
Würthinger et al., Swiss Radiology Congress, St-Gall 2019
Prix du meilleur poster en technologie pharmaceutique :
An MRI-guided HIFU-triggered wax-coated capsule for supertargeted drug release.
Romagna et al., Swiss Pharma Science Day, Berne 2018